Drug Discovery Technologies Market 2018 – Global Analysis and Forecasts to 2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Drug
Discovery Technologies Market: Global Industry Analysis, Trends, Market
Size and Forecasts up to 2024”
report has been added to ResearchAndMarkets.com’s
offering.

The report predicts the global drug discovery technologies market to
grow with a CAGR of 18.4 % over the period of 2018 – 2024.

The report on drug discovery technologies market is a comprehensive
study and presentation of drivers, restraints, opportunities, demand
factors, market size, forecasts, and trends in the global drug discovery
technologies market over the period of 2016 to 2024. Moreover, the
report is collective presentation of primary and secondary research
findings.

Porter’s Five Forces model in the report provides insights into the
competitive rivalry, supplier and buyer positions in the market and
opportunities for the new entrants in the global drug discovery
technologies market over the period of 2016 – 2024. Further, the
author’s Growth Matrix given in the report brings an insight on the
investment areas that existing or new market players can consider.

Segments Covered

The global drug discovery technologies market is segmented on the basis
of technology type, and end users.

Global Drug Discovery Technologies Market by Technology Type

  • Biochips
  • High throughput screening
  • Pharmacogenomics
  • Genomics
  • Bioanalytical instruments
  • Bioinformatics
  • Nanotechnology
  • Others (RNAi, combinatorial chemistry)

Global Drug Discovery Technologies Market by End Users

  • Biopharmaceutical companies
  • Pharmaceutical companies
  • Research institutes
  • Biotech companies

Global Drug Discovery Technologies Market by Regions

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Companies Profiled

  • Agilent Technologies, Inc
  • Abbott Laboratories, Inc.
  • GE Healthcare Ltd.
  • Albany Molecular Research Inc.
  • Affymetrix Inc.
  • Arqule Inc.
  • Luminex Corporation
  • Bayer Healthcare AG
  • Novartis AG
  • Astrazeneca plc

For more information about this report visit https://www.researchandmarkets.com/research/nggdfl/drug_discovery?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Discovery